Cargando…

Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants

BACKGROUND: Decision making for the “best” treatment is particularly challenging in situations in which individual patient response to drugs can largely differ from average treatment effects. By estimating individual treatment effects (ITEs), we aimed to demonstrate how strokes, major bleeding event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meid, Andreas D., Wirbka, Lucas, Groll, Andreas, Haefeli, Walter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189725/ https://www.ncbi.nlm.nih.gov/pubmed/34911402 http://dx.doi.org/10.1177/0272989X211064604

Ejemplares similares

A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation
por: Wirbka, Lucas, et al.
Publicado: (2022)

Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants – A Retrospective Cohort Study in Health Insurance Claims Data
por: Wirbka, Lucas, et al.
Publicado: (2021)

Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data
por: Meid, Andreas D, et al.
Publicado: (2020)

A framework to build similarity-based cohorts for personalized treatment advice – a standardized, but flexible workflow with the R package SimBaCo
por: Wirbka, Lucas, et al.
Publicado: (2020)

Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions
por: Ruff, Carmen, et al.
Publicado: (2021)

The Role of Adherence Thresholds for Development and Performance Aspects of a Prediction Model for Direct Oral Anticoagulation Adherence
por: Ruff, Carmen, et al.
Publicado: (2019)

Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity
por: Rizos, Timolaos, et al.
Publicado: (2022)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

Machine learning for tumor growth inhibition: Interpretable predictive models for transparency and reproducibility
por: Meid, Andreas D., et al.
Publicado: (2022)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
por: Takatsuki, Seiji, et al.
Publicado: (2017)

Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
por: Streif, Werner
Publicado: (2023)

Impact of an electronic clinical decision support system on workflow in antenatal care: the QUALMAT eCDSS in rural health care facilities in Ghana and Tanzania
por: Mensah, Nathan, et al.
Publicado: (2015)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Supporting Real World Decision Making in Coronary Diseases Using Machine Learning
por: Kokol, Peter, et al.
Publicado: (2021)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review()
por: Li, Allen, et al.
Publicado: (2020)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
por: Hutto, David, et al.
Publicado: (2022)

Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
por: Corrochano, Mariana, et al.
Publicado: (2022)

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
por: Vinogradova, Yana, et al.
Publicado: (2018)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

Real-world decision support systems: case studies
por: Papathanasiou, Jason, et al.
Publicado: (2016)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

The impact of a computerized physician order entry system implementation on 20 different criteria of medication documentation—a before-and-after study
por: Jungreithmayr, Viktoria, et al.
Publicado: (2021)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
por: Pham, Phuong N., et al.
Publicado: (2019)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
por: Menéndez-Jándula, Bárbara, et al.
Publicado: (2019)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain
por: Gavín, Olga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ecip03gf873tkgmrcm58fn411p